Ohio Public Employees Retirement System (OPERS)’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
SOCM
BBA
TECP
VC
Ohio Public Employees Retirement System (OPERS)'s DSGN Position: Q2 2026 in Review
Ohio Public Employees Retirement System (OPERS) increased its Design Therapeutics (DSGN) stake by 36% in Q2 2026, buying an estimated $68.7K and bringing the position to 20,700 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #1587.
Ohio Public Employees Retirement System (OPERS) first reported a position in DSGN in Q4 2023 and has held it in 7 quarters since. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) held 20,700 shares of Design Therapeutics worth $300K as of Q2 2026.
- Ohio Public Employees Retirement System (OPERS) bought 5,507 Design Therapeutics shares in Q2 2026, an estimated $68.7K.
- Design Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #1587 holding.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Design Therapeutics in Q4 2023 and has held it in 7 quarters since.
- 136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.